Your browser doesn't support javascript.
loading
Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort.
Fortner, Renée T; Ose, Jennifer; Merritt, Melissa A; Schock, Helena; Tjønneland, Anne; Hansen, Louise; Overvad, Kim; Dossus, Laure; Clavel-Chapelon, Françoise; Baglietto, Laura; Boeing, Heiner; Trichopoulou, Antonia; Benetou, Vassiliki; Lagiou, Pagona; Agnoli, Claudia; Mattiello, Amalia; Masala, Giovanna; Tumino, Rosario; Sacerdote, Carlotta; Bueno-de-Mesquita, H B As; Onland-Moret, N Charlotte; Peeters, Petra H; Weiderpass, Elisabete; Torhild Gram, Inger; Duell, Eric J; Larrañaga, Nerea; Ardanaz, Eva; Sánchez, María-José; Chirlaque, M-D; Brändstedt, Jenny; Idahl, Annika; Lundin, Eva; Khaw, Kay-Tee; Wareham, Nick; Travis, Ruth C; Rinaldi, Sabina; Romieu, Isabelle; Gunter, Marc J; Riboli, Elio; Kaaks, Rudolf.
Afiliação
  • Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ose J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Merritt MA; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Schock H; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Hansen L; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Overvad K; Department of Public Health Aarhus University, Section for Epidemiology, Aarhus, Denmark.
  • Dossus L; U1018, Nutrition, Hormones and Women's Health Team, Inserm, Centre for Research in Epidemiology and Population Health (CESP), Villejuif, France.
  • Clavel-Chapelon F; Université Paris Sud, Unité Mixte de Recherche Scientifique 1018, Villejuif, France.
  • Baglietto L; U1018, Nutrition, Hormones and Women's Health Team, Institut Gustave Roussy, Villejuif, France.
  • Boeing H; U1018, Nutrition, Hormones and Women's Health Team, Inserm, Centre for Research in Epidemiology and Population Health (CESP), Villejuif, France.
  • Trichopoulou A; Université Paris Sud, Unité Mixte de Recherche Scientifique 1018, Villejuif, France.
  • Benetou V; U1018, Nutrition, Hormones and Women's Health Team, Institut Gustave Roussy, Villejuif, France.
  • Lagiou P; Cancer Epidemiology Centre, Cancer Council of Victoria, Melbourne, Australia.
  • Agnoli C; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Australia.
  • Mattiello A; Department of Epidemiology, German Institute of Human Nutrition (DIfE) Potsdam-Rehbrücke, Nuthetal, Germany.
  • Masala G; Hellenic Health Foundation, Athens, Greece.
  • Tumino R; Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.
  • Sacerdote C; Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
  • Bueno-de-Mesquita HB; Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
  • Onland-Moret NC; Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.
  • Peeters PH; Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
  • Weiderpass E; Department of Epidemiology, Harvard School of Public Health, Boston, MA.
  • Torhild Gram I; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Duell EJ; Dipartimento Di Medicina Clinica E Chirurgia, Federco II University, Naples, Italy.
  • Larrañaga N; Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
  • Ardanaz E; Cancer Registry and Histopathology Unit, "Civic-M.P. Arezzo" Hospita, Ragusa, Italy.
  • Sánchez MJ; Unit of Cancer Epidemiology, AO Citta' Della Salute E Della Scienza-University of Turin and Center for Cancer Prevention (CPO), Turin, Italy.
  • Chirlaque MD; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Brändstedt J; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Idahl A; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
  • Lundin E; Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Khaw KT; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, Epidemiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Wareham N; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, Epidemiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Travis RC; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, the Arctic University of Norway, Tromsø, Norway.
  • Rinaldi S; Cancer Registry of Norway, Oslo, Norway.
  • Romieu I; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Gunter MJ; Department of Genetic Epidemiology, Folkhälsan Research Center, Helsinki, Finland.
  • Riboli E; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, the Arctic University of Norway, Tromsø, Norway.
  • Kaaks R; Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
Int J Cancer ; 137(5): 1196-208, 2015 Sep 01.
Article em En | MEDLINE | ID: mdl-25656413
Whether risk factors for epithelial ovarian cancer (EOC) differ by subtype (i.e., dualistic pathway of carcinogenesis, histologic subtype) is not well understood; however, data to date suggest risk factor differences. We examined associations between reproductive and hormone-related risk factors for EOC by subtype in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Among 334,126 women with data on reproductive and hormone-related risk factors (follow-up: 1992-2010), 1,245 incident cases of EOC with known histology and invasiveness were identified. Data on tumor histology, grade, and invasiveness, were available from cancer registries and pathology record review. We observed significant heterogeneity by the dualistic model (i.e., type I [low grade serous or endometrioid, mucinous, clear cell, malignant Brenner] vs. type II [high grade serous or endometrioid]) for full-term pregnancy (phet = 0.02). Full-term pregnancy was more strongly inversely associated with type I than type II tumors (ever vs. never: type I: relative risk (RR) 0.47 [95% confidence interval (CI): 0.33-0.69]; type II, RR: 0.81 [0.61-1.06]). We observed no significant differences in risk in analyses by major histologic subtypes of invasive EOC (serous, mucinous, endometrioid, clear cell). None of the investigated factors were associated with borderline tumors. Established protective factors, including duration of oral contraceptive use and full term pregnancy, were consistently inversely associated with risk across histologic subtypes (e.g., ever full-term pregnancy: serous, RR: 0.73 [0.58-0.92]; mucinous, RR: 0.53 [0.30-0.95]; endometrioid, RR: 0.65 [0.40-1.06]; clear cell, RR: 0.34 [0.18-0.64]; phet = 0.16). These results suggest limited heterogeneity between reproductive and hormone-related risk factors and EOC subtypes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Epiteliais e Glandulares / Anticoncepcionais Orais Hormonais Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged / Pregnancy País/Região como assunto: Europa Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Epiteliais e Glandulares / Anticoncepcionais Orais Hormonais Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged / Pregnancy País/Região como assunto: Europa Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos